EU drug regulator to issue view on J&J vaccine next week


FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) -Europe's drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson's COVID-19 vaccine next week, but that it continued to believe the benefits of the shot outweighed the risks of side effects.

The European Medicines Agency (EMA) is reviewing a small number of cases in the United States of very rare blood clotting disorders among people who had received the J&J vaccine.

The agency also said J&J had recommended EU member states hold on to the doses they had already received until the watchdog's safety committee issues its recommendation.

J&J said on Tuesday it would "proactively delay" the rollout of its vaccine in Europe, after U.S. federal health agencies recommended pausing its use for at least a few days after six women under the age of 50 developed rare blood clots after receiving the shot.

The vaccine was authorised in the European Union on March 11 but widespread use in the bloc has not yet started, trailing a rollout in the United States.

Investigations into rare blood clots linked to AstraZeneca's shot have already hobbled Europe's vaccine rollout. Denmark said on Wednesday it would drop AstraZeneca's vaccine, which is similar to J&J's, over the risk.

(Reporting by Yadarisa Shabong in Bengaluru, Ludwig Burger in Frankfurt; Editing by Aditya Soni and Mark Potter)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

Mexico investigates two opposition governor candidates in northern border state
Singapore PM condemns alleged attack on woman of Indian descent over mask
Palestinian rocket fire, Israeli strikes in Gaza run into second day
Turkish soldier killed, four wounded in Syria's Idlib, defence ministry says
Japanese prefecture says deaths at home surge amid 4th COVID-19 wave
Australia's New South Wales reports zero COVID-19 cases for fifth straight day
Deutsche Bank 1MDB probe dropped by US Justice Department
Myanmar reporters, activists arrested in Thailand
Single dose of AstraZeneca vaccine gives 80% lower death risk
The French tech whiz bringing Covid data to the masses

Stories You'll Enjoy


Vouchers